Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 11
Submit an article Journal homepage
177
Views
17
CrossRef citations to date
0
Altmetric
Original

Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab

A. Unal Faculty of Medicine, Dedeman Hospital, Division of Hematology-Oncology, Department of Medicine
,
I. Sari Faculty of Medicine, Dedeman Hospital, Division of Hematology-Oncology, Department of MedicineCorrespondence[email protected] [email protected]
, MD,
K. Deniz Department of Pathology, Erciyes University, 38039, Kayseri, Turkey
,
M. Ozkan Faculty of Medicine, Dedeman Hospital, Division of Hematology-Oncology, Department of Medicine
,
O. Kontas Department of Pathology, Erciyes University, 38039, Kayseri, Turkey
,
B. Eser Faculty of Medicine, Dedeman Hospital, Division of Hematology-Oncology, Department of Medicine
&
M. Cetin Faculty of Medicine, Dedeman Hospital, Division of Hematology-Oncology, Department of Medicine
 show all
Pages 1613-1617 | Received 20 Jun 2005, Published online: 01 Jul 2009

References

  • Shpilberg G, Modan M, Modan B, Chetrit A, Fuchs Z, Ramot B. Familial aggregation of hematological neoplasms: a controlled study. Br J Haematol 1994; 87: 75–80
  • Greene M H, Brinton L A, Fraumeni J J, D'Amico R. Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet 1978; 2: 626–627
  • Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer 1982; 49: 2197–2200
  • Kerzin-Storrar L, Faed M JW, MacGillivray J B, Smith P G. Incidence of familial Hodgkin's disease. Br J Cancer 1983; 47: 707–712
  • Mack T M, Cozen W, Shibata D K, Weiss L M, Nathwani B N, Hernandez A M, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the youngadult form of the disease. N Engl J Med 1995; 332: 413–418
  • Greene M H, McKeenn E Z, Li F P, Blattner W A, Fraumeni J F. HLA antigens in familial Hodgkin's Disease. Int J Cancer 1979; 23: 777–780
  • Hors J, Daussel J. HLA and susceptibility to Hodgkin's disease. Immunol Rev 1983; 70: 167–192
  • Harty L C, Lin A Y, Goldstein A M, Juffe E S, Currington M, Tucker M A, et al. HLA-DR, HLA-DQ and TAP genes in familial Hodgkin's disease. Blood 2002; 99: 690–693
  • Grufferman S, Delzell E. Epidemiology of Hodgkin's disease. Epidemiol Rev 1984; 6: 76–106
  • Campbell G N, Lloyd J, Wotherspoon A, Coulter C, Bain B J. Nodular lymphocyte predominant Hodgkin lymphoma in siblings. Leuk Lymphoma 2004; 45: 609–611
  • Colby T, Hoppe R, Warnke R. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer 1982; 49: 1848–1858
  • Tubiana M, Henry-Amar M, Carde P. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964 – 1987. Blood 1989; 73: 47–56
  • Schlembach P J, Wilder R B, Jones D, Ha C S, Fayad L E, Younes A, et al. Radiotherapy alone for lymphocyte-predominant Hodgkin's disease. Cancer J 2002; 8: 377–383
  • Miettinen M, Franssila K O, Saxen E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer J 1983; 51: 2293–2300
  • Diehl V, Sextro M, Franklin J, Hansmann M L, Harris N, Jaffe E, Poppema S. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999; 17: 776–783
  • Chittal S M, Brousset P, Voigt J J, Delsol G. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 1991; 19: 211–220
  • Kielholz U, Szelenya H, Siehl J, Foss H D, Knauf W, Thiel E. Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD20 monoclonal antibody) and interleukin-2. Leuk Lymphoma 1999; 35: 641–642
  • Lush R J, Jones S G, Haynes A P. Advanced-stage, chemorefractory lymphocyte-predominant Hodgkin's disease: long-term follow-up of allografting and monoclonal antibody therapy. Br J Haematol 2001; 114: 734–735
  • Rehwald U, Schulz H, Reiser M, Sieber M, Staak J O, Morschhauser F, et al. German Hodgkin Lymphoma Study Group (GHSG). Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 2003; 101: 420–424
  • Ekstrand B C, Lucas J B, Horwitz S M, Fan Z, Breslin S, Hoppe R T, et al. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood 2003; 101: 4285–4289
  • Ramsay A D, Smith W J, Isaacson P G. T-cell-rich-B-cell lymphoma. Am J Surg Pathol 1988; 12: 433–443
  • Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini M P, Stul M, et al. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 1992; 16: 37–48
  • De Jong D, Van Gorp J, Sie-Go D, Van Heerde P. T-cell rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease. Histopathology 1996; 28: 15–24
  • McBride J A, Rodriguez J, Luthra R, Ordonez N G, Cabanillas F, Pugh W C. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol 1996; 20: 193–201

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.